Santen Pharmaceutical Co. Ltd. Registered Shares o.N.

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

17.28%

Market Cap

-

P/E Ratio

15.66

Dividend Yield

2.13 %

Earnings per Share

0.65 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE10.9 G0 Units
PRICE DETERMINATION TIME07/21/2026 / 09:56:27 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW10.910.7
PREV. DAY'S PRICE11.2 (07/20)
CHANGE DAY BEFORE
-0.30
-2.68 %
52 WEEK HIGH / LOW12 (07/03)8.15 (10/29)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
0.460.640.650.660.70
DIVIDENDS PER SHARE
0.210.220.220.230.25
DIVIDEND YIELD IN %
2.15 %2.54 %2.13 %--
DIVIDEND GROWTH IN %
-7.37 %4.43 %-1.10 %--
PRICE - EARNINGS RATIO
21.1713.6415.6616.7115.69
PRICE - BOOK RATIO
1.821.691.93--
PRICE - SALES RATIO
1.871.652.01--
PRICE - CASH FLOW RATIO
7.798.1413.48--
Further Key Figures

Master Data

WKN
864318
ISIN
JP3336000009
SYMBOL
SZD
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
SANTEN PHARMA.
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
-
MARKET CAPITALISATION
-

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-2.61 %
10.89 %
20.43 %
22.40 %
17.28 %
47.37 %
-2.61 %
28.74 %
HIGH11.5012.0012.0012.0012.0012.0013.0012.00
LOW10.8010.308.308.308.157.606.408.30

Dividende

pro Aktie

Company profile

Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the following segments: Pharmaceuticals and Others. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products. The Others segment offers medical equipment and devices. The company was founded by Kenkichi Tagushi in 1890 and is headquartered in Osaka, Japan.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.